Table 3.
T2 baseline lesions | CEL | PPV (95% CI) |
---|---|---|
Unknown | Unknown | 4.7% (2.1%, 7.7%) |
⩾10 | Unknown | 8.0% (7.2%, 8.9%) |
⩾10 | ⩾1 | 12.7% (8.6%, 16.9%) |
⩾10 | ⩾2 | 16.3% (10.2%, 22.7%) |
⩾10 | ⩾5 | 18.2% (4.8%, 33.3%) |
⩾10 | ⩾10 | 36.4% (12.5%, 66.7%) |
⩾20 | Unknown | 11.5% (8.6%, 13.9%) |
⩾20 | ⩾1 | 15.8% (9.8%, 22.4%) |
⩾20 | ⩾2 | 18.9% (10.6%, 28.1%) |
⩾20 | ⩾5 | 22.2% (6.3%, 41.7%) |
⩾20 | ⩾10 | 40.0% (14.3%, 71.4%) |
MS: multiple sclerosis; CEL: contrast-enhancing lesions; PPV: positive predictive value; 95% CI: 95% confidence interval.